Bernstein Downgrades Alnylam to Market Perform, Cuts Target to $199
Bernstein lowered its price target from $376 to $199. The new target implies 14.4% upside from Alnylam’s Oct. 29 close of $174.
Bernstein lowered its price target from $376 to $199. The new target implies 14.4% upside from Alnylam’s Oct. 29 close of $174.